Armata Pharmaceuticals (ARMP) Operating Income: 2013-2018
Historic Operating Income for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$2.8 million.
- Armata Pharmaceuticals' Operating Income fell 18.14% to -$2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$17.2 million, marking a year-over-year decrease of 6.34%. This contributed to the annual value of -$42.4 million for FY2024, which is 3.78% down from last year.
- Armata Pharmaceuticals' Operating Income amounted to -$2.8 million in Q4 2018, which was down 15.03% from -$2.4 million recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Operating Income ranged from a high of -$746,000 in Q3 2017 and a low of -$11.9 million during Q4 2016.
- Its 3-year average for Operating Income is -$4.9 million, with a median of -$3.4 million in 2016.
- Its Operating Income has fluctuated over the past 5 years, first crashed by 303.54% in 2016, then soared by 80.07% in 2017.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Operating Income stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then slumped by 303.54% to -$11.9 million in 2016, then skyrocketed by 80.07% to -$2.4 million in 2017, then declined by 18.14% to -$2.8 million in 2018.
- Its Operating Income stands at -$2.8 million for Q4 2018, versus -$2.4 million for Q3 2018 and -$9.6 million for Q2 2018.